N 233 Ovacs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from N 233 ovacs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In N 233 Ovacs Today - Breaking & Trending Today
PARIS, France, January 19th, 2023, at 8h30 (CET) - Néovacs (FR00140077X1 - ALNEV), a French biotech company specializing in therapeutic vaccines for the treatment of autoimmune diseases ....
Increase in the funding commitment of Néovacs to cover cash requirements through the topline results of the pivotal Phase III clinical study of the drug candidate PXT3003, the PREMIER trial, in development ....
DJ Pharnext strengthens its ties with Néovacs to secure the next steps in its development Pharnext Pharnext strengthens its ties with Néovacs to secure the next steps in its development 28-Dec-2022 ....
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement ....
DJ Pharnext Announces a EUR2.5m Loan Agreement with Néovacs Pharnext Pharnext Announces a EUR2.5m Loan Agreement with Néovacs 23-Aug-2022 / 08:30 CET/CEST Dissemination of a French Regulatory News ....